Top Markets
#1 Status Status +26.96%
#2 Ontology Gas Ontology Gas +26.36%
#3 EXOD EXOD +22.08%
#4 ETHGas ETHGas +11.00%
#5 Fake World Assets Fake World Assets +10.37%
#6 aelf aelf +9.25%
#7 The Black Bull The Black Bull +8.43%
#8 Derive Derive +8.38%
#9 Gas Gas +8.36%
#10 Ontology Ontology +6.93%
Coin of the day
Status Status
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Rang in Aktien #25548
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Aktienkurs
$20.01
Zuletzt synchronisiert: 2025-02-21
Marktkapitalisierung
$48.36M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Singular Genomics Systems, Inc. (OMIC)

Kategorie

Healthcare
Operative Marge für Singular Genomics Systems, Inc. (OMIC)
Operative Marge zum August 2026 TTM: -3,531.47%
Laut den neuesten Finanzberichten und dem Aktienkurs von Singular Genomics Systems, Inc. beträgt die aktuelle operative Marge (TTM) -3,531.47%. Am Ende des Jahres 2022 lag die operative Marge bei -12,220.52%.
Historie der operativen Marge von Singular Genomics Systems, Inc. von 2019 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) -3,531.47% 0.00%
2023 -3,531.47% -71.10%
2022 -12,220.52% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
31.28% -100.01%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
12.36% -100.00%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
0.00% -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
9.83% -100.00%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
0.00% -
CH
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.